Characteristics | Total | Non-oncological | Oncological | p-value |
---|---|---|---|---|
Total (%) | 778 | 212 (27.2) | 566 (72.8) | |
Age, years mean ± SD | 75.3 ± 12.2 | 81.6 ± 10.5 | 72.9 ± 11.9 | < .001 |
Gender, n (%) | .055 | |||
Female | 404 (51.9) | 122 (57.5) | 282 (49.8) | |
Male | 374 (48.1) | 90 (42.5) | 284 (50.2) | |
AKPS, median (range) | 40 (10–90) | 20 (10–70) | 40 (10–90) | |
Length of episode, mean ± SD, days | 18.6 ± 19.4 | 15.3 ± 17.1 | 19.8 ± 20.0 | .004 |
Episodes end with death, n (%) | 400 (51.4) | 141 (66.5) | 259 (45.8) | .000 |
missing n (%) | 4 (0.5) | 0 | 4 (0.7) | |
Diagnosis, n (%) | ||||
Oncological | 566 (100.0) | |||
Lip, mouth, pharynx | 12 (2.1) | |||
Gastrointestinal | 158 (27.9) | |||
Respiratory | 130 (23.0) | |||
Melanoma | 12 (2.1) | |||
Neurology | 9 (1.6) | |||
Mamma | 51 (9.0) | |||
Genitourinary | 123 (21.7) | |||
Eye, Head, CNS | 10 (1.8) | |||
Endocrinology | 1 (0.2) | |||
Others | 60 (10.6) | |||
Non-oncological | 212 (100.0) | |||
Mental and behavioral disorders | 30 (14.2) | |||
Neurology | 37 (17.5) | |||
Circulatory | 71 (33.5) | |||
Respiratory | 38 (17.9) | |||
Gastrointestinal | 18 (8.5) | |||
Genitourinary | 16 (7.5) | |||
Others | 2 (0.9) |